|USA: Bush Blocks Cheap Drugs for World's Poor|
by Charlotte Denny, Guardian/UK
February 19th, 2003
George Bush's close links with the drugs industry were last night blamed for the failure of talks in Geneva aimed at securing access to cheap medicines for developing countries.
|Brazil: Hopes Lift at WTO Drugs Talks|
by Bayan Rahman, Financial Times
February 17th, 2003
Brazilian proposal at the weekend has raised hopes of a breakthrough in the World Trade Organisation's deadlocked talks on poor ountries' access to essential medicines.
|USA: Drug Industry Poised to Reap Political Dividends|
by Vicki Kemper, Los Angeles Times
November 8th, 2002
Few industries campaigned harder than pharmaceutical manufacturers to elect Republicans to the new Congress, and few industries are better positioned to reap the rewards of the election returns, analysts said Thursday.
|USA: Feds Pushing Toxic Anthrax Drug?|
by Elliot Borin, Wired.com
October 24th, 2002
Many veterans' advocates believe a certain anthrax vaccine to be a major cause of Gulf War sickness. The company manufacturing it has launched a massive lobbying campaign to persuade the Bush administration to stockpile the controversial drug so it can be administered to civilians.
|World: AIDS Activists Mobilize Against Coca-Cola|
by Jim Lobe, OneWorld US
October 17th, 2002
AIDS activists are preparing rallies and demonstrations Thursday in several cities around the world to protest against global soft-drink giant Coca-Cola, which they charge must do more to help and treat its HIV-infected workers and their families in sub-Saharan Africa.
|USA: Hormone Replacement Only the Tip of the Iceberg|
by Lynn Landes, AlterNet
July 31st, 2002
The HRT (Hormone Replacement Therapy) scandal is bigger than most think. It's not just about menopausal women, like me, getting bad information from their physicians and the pharmaceutical industry for over 40 years, while the federal government stood by and did nothing. The scandal is much bigger than that.
|USA: Hormonal Outrage at Pharmaceuticals|
by Sharon Lerner, Village Voice
July 16th, 2002
Last week, after its findings revealed that the combination of hormones taken by some 6 million women was doing more harm than good, causing an increase in heart attacks, breast cancer, blood clots, and strokes, a national study was halted mid-stream. Wyeth, which has raked in more than $2 billion a year from its top-selling hormone therapies is now watching its stock price dive.
|Kenya: HIV Drug Shortages 'Critical'|
April 9th, 2002
JOHANNESBURG -- A severe shortage of two antiretrovirals (ARVs) produced by leading pharmaceutical Bristol-Myers Squibb in Kenya, could have critical repercussions for patients, says Medecines sans Frontieres (MSF).
|Bayer Won't Pull Poultry Antibiotics|
November 1st, 2001
Recent threats of bioterrorism have highlighted how important it is to safeguard the effectiveness of America's antibiotics supply. But when the Food and Drug Administration (FDA) recently proposed a ban on the use of certain antibiotics to treat sick chickens and turkeys, Bayer Corporation refused to comply.
|India: Kerala to Protect Tribal Intellectual Property Rights|
by Liz Mathew, Indo Asian News Service
September 22nd, 2001
NEW DELHI -- The Kerala government has decided to introduce legislation to protect the intellectual property rights of its tribespeople who have been practising traditional nature-based medicine for centuries.
|UN: African Leaders Say Debt Hampers Fight Against AIDS|
by Lewis Machipisa, Inter Press Service
June 25th, 2001
African leaders used the opening of the UN General Assembly Special Session on HIV-AIDS Monday to assail the international community's response to the deadly epidemic for failing to match the speed and seriousness with which the disease is infecting their citizens. Official after official rose to drive home the message that the death of more than 20 million people, mostly in sub-Saharan Africa, demands that more money be committed to the fight.
|South Africa: Drug Companies Drop AIDS Suit|
by Ravi Nessman, Associated Press
April 19th, 2001
In a move activists hoped would lead to a flood of affordable AIDS medication to Africa, the pharmaceutical industry dropped its suit Thursday challenging a South African law many say would allow the government to import or produce generic versions of the drugs.
|USA: The Pharmaceutical Industry Stalks the Corridors of Power|
by Julian Borger, The Guardian Unlimited
February 13th, 2001
In this pantheon of corporate muscle, no industry wields as much power as the Pharmaceutical Research and Manufacturers Association (PhRMA), a pressure group breathtaking for its deep pockets and aggression, even by the standards of US politics.
|USA: Ten Worst Corporations of 2000|
by Russell Mokhiber and Robert Weissman, Focus on the Corporation
January 3rd, 2001
Here is the annual Top 10 Worst Corporations of 2000 list compiled by Russell Mokhiber and Robert Weissman. This year, rushing to the head of the pack of irresponsible biotech companies was the French corporation Aventis, the maker of Cry9C corn, sold under the name StarLink.
|USA: Health Care Firms Spend Big to Head Off Reforms|
by Jeff Leeds, Los Angeles Times
July 23rd, 2000
With billions of dollars in profits on the line, the health care industry is waging the largest national advertising campaign ever conducted by a political special interest, with a price tag for the election cycle that could approach $90 million--more than either of the major presidential candidates is expected to spend.
|South Africa: AIDS Protestors Picket Pfizer|
June 26th, 2000
JOHANNESBURG, South Africa About 100 picketers demonstrated Monday outside the offices of the Pfizer drug company, saying its offer of free treatment for an AIDS-related brain infection was insufficient.
|UK: A Bitter Pill for the World's Poor|
by Isabel Hilton, The Guardian
January 5th, 2000
It is a story repeated daily in towns and villages across the developing world. Whatever the recorded cause of death - leishmaniasis, tuberculosis, pneumonia - the real cause is poverty. Poor people in tropical countries are at risk from a range of diseases for which they cannot get treatment - either because medicines are available at prices they cannot afford or, worse still, because no medicines are available.